Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine
about
Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infectionIntrapartum antibiotics for known maternal Group B streptococcal colonizationGroup B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countriesBacterial meningitis in infantsChallenges in reducing group B Streptococcus disease in African settings.Carriage and serotype distribution of Streptococcus agalactiae in third trimester pregnancy in southern Ghana.Current management and long-term outcomes following chorioamnionitis.Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.Invasive group B streptococcal infection in infants in Shenzhen, ChinaMaternal group B Streptococcus and the infant gut microbiota.Frequency of Pathogenic Paediatric Bacterial Meningitis in Mozambique: The Critical Role of Multiplex Real-Time Polymerase Chain Reaction to Estimate the Burden of Disease.Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trialEmergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains.Estimating the burden of invasive Group B Streptococcal disease in young infants in southern mainland China: an observational studyRisk factors for infectious disease death among infants in the United StatesTemporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine DevelopmentMaternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya.Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial.Evaluation of procedures for typing of group B Streptococcus: a retrospective study.Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.An unusual case of a large, sporadic intra-abdominal abscess due to group B Streptococcus and a review of the literature.Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease.Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.Prevention of early onset group B streptococcal disease by universal antenatal culture-based screening in all public hospitals in Hong Kong.Reduced incidence of neonatal early onset group B streptococcal infection after promulgation of guidelines for risk-based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population-based cohort.Colonization prevalence and antibiotic susceptibility of Group B Streptococcus in pregnant women over a 6-year period in Dongguan, China.Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.The aetiology of paediatric bloodstream infections changes after pneumococcal vaccination and group B streptococcus prophylaxis.Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review.Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.Co-association between Group B Streptococcus and Candida albicans promotes interactions with vaginal epithelium.Clinical and laboratory features of Group B Streptococcus meningitis in infants and newborns: study of 848 cases in France from 2001-2014.Screening for group B Streptococcus (GBS) at labour onset using PCR: accuracy and potential impact - a pilot study.A vaginal tract signal detected by the GBS SaeRS system elicits transcriptomic changes and enhances murine colonization.Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.Epitope Mapping of Streptococcus agalactiae Elongation Factor Tu Protein Recognized by Human Sera.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.
P2860
Q24187315-FDFB7A5D-F71C-4326-9F69-316B5E3622D0Q24194038-FADEE9B2-8C2E-4C99-943E-D99BDBA93CCDQ28075884-953D4417-1702-4795-9A92-862484FC283CQ28082173-3AF05AA8-72F4-4C65-9041-8C04DB142BD5Q30241490-ABC461BF-1A2F-45BE-B0A8-E7601280BD83Q33921927-D742976A-7F46-4B79-847D-64E0968035A4Q34624861-7FB14CCF-C32B-4ABB-B8CA-DD56C091432DQ35122775-8919B4D1-A1D4-4297-BB36-78B3653C1A9EQ35306303-893B0FAC-00F1-4EF3-93C9-FC0809E7A22CQ35481809-6334705A-3AAB-4338-950C-F844D180ABC5Q35743110-9E424B36-26B0-4E14-AF10-5A7F33F18B4DQ35783402-4519E8D0-D5FE-492D-8D53-C4230487FEE3Q35846420-7438CD75-8BA1-455A-ABEA-9D6485FD6CA9Q35968715-DAB9A6A8-7F58-4BC4-96E2-30785F5FE505Q36183228-D30BA1A5-56E3-44F3-8C02-E5FA472E2F64Q36192481-2A7D7C80-FF9E-4CAE-A7DE-19FD9B9F2D1FQ36236399-2274A82E-F459-4AC6-B71C-4D620601E707Q37074413-02356650-915B-45D7-81C6-93EF895F4FDEQ37074749-5ED9016D-AB52-4795-B530-FB6536D12FEDQ37710063-0BC323AA-E559-4FDF-A4F3-DF12F88D3A8DQ38253017-2520371C-AA34-4001-B61E-D4B408676008Q38254726-BDC475EA-CB55-4F21-AEEB-3E2D55F70263Q38660625-B855BCFD-12FD-45F3-99C7-6665101C2209Q38817784-8644BBE8-80BC-483A-AF5B-1B309631A128Q38893046-5145664E-DE6B-427E-AA0C-76499E049C60Q40073944-AE557658-55EA-448E-89BC-96F1F12B48F1Q40091480-54EE30BC-98D9-4A01-874B-98EF5AE902EAQ40410171-222EECE4-D656-416B-8508-FF15BFADBC2CQ40851776-0A66D299-8685-4DA0-B4A7-76C60ABCAECDQ46126306-ED22DB41-3560-4C93-B940-2AFDC31D13DBQ46873175-49F7FEC5-8A91-4FC0-AE3F-263A5461B6FCQ47546256-30B48608-7D49-4549-989C-5A671C1B7D3EQ47552646-4447F17D-6227-4502-8869-AD98D5464804Q47767787-6561070F-676B-48A9-AE0B-30D0471368C2Q48310970-565EA3C3-19D7-4A42-A3D9-9C208DD983EAQ49597974-F654BC9A-FA70-4378-8259-01FD6A5298B0Q49631079-EDFF072E-9334-4E15-BEB4-419140199EB5Q50300767-0AE0F998-5EDE-4A75-869B-01BDB251D178Q52624533-BA5A227A-91DB-46EA-BC65-95D6DD4A2B94Q52665560-3C0C83BD-C21E-4037-965F-3F44FB6E9880
P2860
Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@ast
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@en
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@nl
type
label
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@ast
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@en
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@nl
prefLabel
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@ast
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@en
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@nl
P3181
P1433
P1476
Intrapartum antibiotic prophyl ...... group B streptococcal vaccine
@en
P2093
Jennifer R Verani
Stephanie J Schrag
P3181
P356
10.1016/J.VACCINE.2012.11.056
P407
P478
31 Suppl 4
P577
2013-08-28T00:00:00Z